title: Short-term effects of atorvastatin on haemorheologic parameters, platelet aggregation and endothelium dysfunction in patients with hypercholesterolaemia.
authors.forename: Beata
authors.initials: B
authors.lastname: Horvath
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Marton
authors.forename: Tamas
authors.initials: T
authors.lastname: Alexy
authors.forename: Gabor
authors.initials: G
authors.lastname: Kesmarky
authors.forename: Kalman
authors.initials: K
authors.lastname: Toth
authors.forename: Laszlo
authors.initials: L
authors.lastname: Szapary
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000941:Antigens / Q000378:metabolism; D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D011758:Pyrroles / Q000627:therapeutic use*; D014841:von Willebrand Factor / Q000276:immunology
chemical_list: D000924:Anticholesteremic Agents; D000941:Antigens; D006538:Heptanoic Acids; D011758:Pyrroles; C029417:Von Willebrand antigen; D014841:von Willebrand Factor; D002784:Cholesterol; D000069059:Atorvastatin